Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amvofer XT
- Development stage
- Unknown
- Lead developer
- Amvia Biotech
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Amvofer XT is an oral hematinic supplement formulated as a syrup, developed by Amvia Biotech. It contains a combination of ferrous ascorbate (30 mg), folic acid (550 mcg), and cyanocobalamin (7.5 mcg). Ferrous ascorbate provides a highly bioavailable form of elemental iron, which is a critical component of hemoglobin, the protein in red blood cells responsible for oxygen transport. Folic acid (Vitamin B9) and cyanocobalamin (Vitamin B12) are essential vitamins that serve as cofactors in DNA synthesis and the maturation of erythrocytes (erythropoiesis). This combination is primarily indicated for the prevention and treatment of iron deficiency anemia in both pediatric and adult populations, addressing nutritional deficiencies that impair red blood cell production.
- Brand names
- Amvofer XT
02
Targets
MTR (Methionine synthase)DHFR (Dihydrofolate reductase)
Beyond the preview
Go deeper on Amvofer XT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amvofer XT.